Literature DB >> 21470877

Ischemia-reperfusion injury-induced pulmonary mitochondrial damage.

Sebastian-Patrick Sommer1, Stefanie Sommer, Bhanu Sinha, Jakob Wiedemann, Christoph Otto, Ivan Aleksic, Christoph Schimmer, Rainer G Leyh.   

Abstract

BACKGROUND: Mitochondrial dysfunction is a key factor in solid organ ischemia-reperfusion (IR) injury. Impaired mitochondrial integrity predisposes to cellular energy depletion, free radical generation, and cell death. This study analyzed mitochondrial damage induced by warm pulmonary IR.
METHODS: Anesthetized Wistar rats received mechanical ventilation. Pulmonary clamping was followed by reperfusion to generate IR injury. Rats were subjected to control, sham, and to 2 study group conditions: 30 minutes of ischemia without reperfusion (IR30/0), or ischemia followed by 60 minutes of reperfusion (IR30/60). Pulmonary edema was quantified by wet/dry-weight ratio. Polarography determined activities of respiratory chain complexes. Mitochondrial viability was detected by using Ca(2+)-induced swelling, and integrity by citrate synthase assay. Enzyme-linked immunosorbent assay determined cytochrome C content. Mitochondrial membrane potential (ΔΨm) stability was analyzed by flow cytometry using JC1, inflammation by myeloperoxidase (MPO) activity, and matrix-metalloproteinase-9 (MMP-9) activity by gel zymography, respectively.
RESULTS: In IR30/60 rats, tissue water content was elevated from 80.6 % (sham) to 86.9%. After ischemia, ΔΨm showed hyperpolarization and rapid decline after uncoupling compared with controls. IR, but not ischemia alone, impaired respiratory chain function complexes I, II and III (p < 0.05). Mitochondrial viability (p < 0.001) and integrity (p < 0.01) was impaired after ischemia and IR, followed by mitochondrial cytochrome C loss (p < 0.05). Increased activation of MPO (p < 0.01) and MMP-9 (p < 0.001) was induced by reperfusion after ischemia.
CONCLUSIONS: Ischemia-related ΔΨm hyper-polarization induces reperfusion-associated mitochondrial respiratory chain dysfunction in parallel with tissue inflammation and degradation. Controlling ΔΨm during ischemia might reduce IR injury.
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21470877     DOI: 10.1016/j.healun.2011.02.001

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  16 in total

1.  Methylene Blue Protects the Isolated Rat Lungs from Ischemia-Reperfusion Injury by Attenuating Mitochondrial Oxidative Damage.

Authors:  Wen-Fang Tian; Si Zeng; Qiong Sheng; Jun-Liang Chen; Ping Weng; Xiao-Tong Zhang; Jia-Jia Yuan; Qing-Feng Pang; Zhi-Qiang Wang
Journal:  Lung       Date:  2017-12-04       Impact factor: 2.584

2.  Mitochondrial transplantation enhances murine lung viability and recovery after ischemia-reperfusion injury.

Authors:  Kamila Moskowitzova; Arzoo Orfany; Kaifeng Liu; Giovanna Ramirez-Barbieri; Jerusha K Thedsanamoorthy; Rouan Yao; Alvise Guariento; Ilias P Doulamis; David Blitzer; Borami Shin; Erin R Snay; James A H Inkster; Khadija Iken; Alan B Packard; Douglas B Cowan; Gary A Visner; Pedro J Del Nido; James D McCully
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-06       Impact factor: 5.464

Review 3.  Pharmacologic Protection of Mitochondrial DNA Integrity May Afford a New Strategy for Suppressing Lung Ischemia-Reperfusion Injury.

Authors:  Yong B Tan; Sujata Mulekar; Olena Gorodnya; Michael J Weyant; Martin R Zamora; Jon D Simmons; Tiago Machuka; Mark N Gillespie
Journal:  Ann Am Thorac Soc       Date:  2017-09

4.  Irisin protects mitochondria function during pulmonary ischemia/reperfusion injury.

Authors:  Ken Chen; Zaicheng Xu; Yukai Liu; Zhen Wang; Yu Li; Xuefei Xu; Caiyu Chen; Tianyang Xia; Qiao Liao; Yonggang Yao; Cindy Zeng; Duofen He; Yongjian Yang; Tao Tan; Jianxun Yi; Jingsong Zhou; Hua Zhu; Jianjie Ma; Chunyu Zeng
Journal:  Sci Transl Med       Date:  2017-11-29       Impact factor: 17.956

5.  Glutathione preconditioning ameliorates mitochondria dysfunction during warm pulmonary ischemia-reperfusion injury.

Authors:  Sebastian-Patrick Sommer; Stefanie Sommer; Bhanu Sinha; Daniel Walter; Ivan Aleksic; Bernhard Gohrbandt; Christoph Otto; Rainer G Leyh
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

6.  Glycine preconditioning to ameliorate pulmonary ischemia reperfusion injury in rats.

Authors:  Sebastian-Patrick Sommer; Stefanie Sommer; Bhanu Sinha; Rainer G Leyh
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-20

7.  Depleted energy charge and increased pulmonary endothelial permeability induced by mitochondrial complex I inhibition are mitigated by coenzyme Q1 in the isolated perfused rat lung.

Authors:  Robert D Bongard; Ke Yan; Raymond G Hoffmann; Said H Audi; Xiao Zhang; Brian J Lindemer; Mary I Townsley; Marilyn P Merker
Journal:  Free Radic Biol Med       Date:  2013-08-01       Impact factor: 7.376

8.  Experimental lung injury promotes alterations in energy metabolism and respiratory mechanics in the lungs of rats: prevention by exercise.

Authors:  Maira J da Cunha; Aline A da Cunha; Emilene B S Scherer; Fernanda Rossato Machado; Samanta O Loureiro; Rodrigo B Jaenisch; Fátima Guma; Pedro Dal Lago; Angela T S Wyse
Journal:  Mol Cell Biochem       Date:  2013-12-31       Impact factor: 3.396

9.  PI3K/Akt pathway-mediated HO-1 induction regulates mitochondrial quality control and attenuates endotoxin-induced acute lung injury.

Authors:  Jia Shi; Jianbo Yu; Yuan Zhang; Lili Wu; Shuan Dong; Lina Wu; Lingzhi Wu; Shihan Du; Yanfang Zhang; Daqing Ma
Journal:  Lab Invest       Date:  2019-09-30       Impact factor: 5.662

10.  Novel Flurometric Tool to Assess Mitochondrial Redox State of Isolated Perfused Rat Lungs after Exposure to Hyperoxia.

Authors:  R Sepehr; S H Audi; K S Staniszewski; S T Haworth; E R Jacobs; M Ranji
Journal:  IEEE J Transl Eng Health Med       Date:  2013-10-16       Impact factor: 3.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.